A preclinical drug candidate with antiviral activity against multiple viruses, including coronaviruses, adenoviruses, and influenza viruses, showing high oral bioavailability and low likelihood of inducing drug resistance.

A platform of broad-spectrum antiviral drugs targeting RNA processing to prevent replication of various viruses, reducing the chance of drug resistance.